Facebook PixelTripping into a better future: can we use non-addictive psychedelic drugs against the downsides of ageing?
Brainstorming
Brainstorming
Brainstorming session

Tripping into a better future: can we use non-addictive psychedelic drugs against the downsides of ageing?

Tripping into a better future: can we use non-addictive psychedelic drugs against the downsides of ageing?

Image credit: Carlos De Soto Molinari

By Subash Chapagain on Oct 01, 2020

[1] https://www.nytimes.com/2017/07/17/upshot/can-psychedelics-be-therapy-allow-research-to-find-out.html

[2] https://michaelpollan.com/articles-archive/the-new-science-of-psychedelics/

[3] Bauer, B. (2019). Psilocybin receives FDA breakthrough treatment designation. Psychedelic Science Review.Retrieved from https:// psychedelicreview.com/psilocybin-receives-fda-breakthroughtreatment- designation/.

[4] Family, N., Maillet, E. L., Williams, L. T. J., Krediet, E., Carhart-Harris, R. L., Williams, T. M., Nichols, C. D., Goble, D. J., & Raz, S. (2019). Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Psychopharmacology, 237(3), 841–853. https://doi.org/10.1007/s00213-019-05417-7

[5] Carhart-Harris, R. L., Kaelen, M., & Nutt, D. (2014). How do hallucinogens work on the brain? The Psychologist 662–665.

[6] Galvan, V., & Jin, K. (2007). Neurogenesis in the aging brain. Clinical Interventions in Aging, 2, 605–610

[7] Ly, C., Greb, A. C., Cameron, L. P.,Wong, J. M., Barragan, E. V.,Wilson, P. C., &…Duim,W. C. (2018). Psychedelics promote structural and functional neural plasticity. Cell Reports, 23, 3170–3182. https://doi.org/10.1016/j.celrep.2018.05.022.

[8] Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016). Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology, 233, 3395–3403. https://doi. org/10.1007/s00213-016-4377-8.

[9] Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D.W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29, 280–288. https://doi. org/10.1177/0269881114565653.

[10] Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, 268–283. https://doi.org/10.1007/ s00213-006-0457-5.

[11] Kelmendi, B., Corlett, P., Ranganathan,M., D’Souza, C., & Krystal, J. H. (2016). The role of psychedelics in palliative care reconsidered: A case for psilocybin. Journal of Psychopharmacology, 30, 1212– 1214. https://doi.org/10.1177/0269881116675781

Creative contributions

Your creative contribution

0 / 200

Added via the text editor